James M. Frincke, CEO at Harbor BioSciences, Inc. (HRBR), bought 50,000 shares at $0.16 ($8K) on 2011-10-28, disclosed to the SEC on 2011-10-31.
Open-market purchase of $8k HRBR by CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.16 | 25,000 | $4K | 50.0% |
| 2 | $0.16 | 25,000 | $4K | 50.0% |
| Total | $0.16 avg | 50,000 | $8K | 100% |
| Filing → |